AVEO Pharmaceuticals (AVEO Pharmaceuticals) Days Inventory : 27.92 (As of Sep. 2022)

View and export this data going back to 2010. Start your Free Trial

What is AVEO Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). AVEO Pharmaceuticals's Average Total Inventories for the three months ended in Sep. 2022 was $1.21 Mil. AVEO Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2022 was $3.96 Mil. Hence, AVEO Pharmaceuticals's Days Inventory for the three months ended in Sep. 2022 was 27.92.

The historical rank and industry rank for AVEO Pharmaceuticals's Days Inventory or its related term are showing as below:

AVEO' s Days Inventory Range Over the Past 10 Years
Min: 44.63 Med: 127.6 Max: 127.6
Current: 44.63

During the past 13 years, AVEO Pharmaceuticals's highest Days Inventory was 127.60. The lowest was 44.63. And the median was 127.60.

AVEO's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 191.14 vs AVEO: 44.63

AVEO Pharmaceuticals's Days Inventory declined from Sep. 2021 (65.51) to Sep. 2022 (27.92).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. AVEO Pharmaceuticals's Inventory Turnover for the three months ended in Sep. 2022 was 3.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. AVEO Pharmaceuticals's Inventory-to-Revenue for the three months ended in Sep. 2022 was 0.04.

AVEO Pharmaceuticals Days Inventory Historical Data

The historical data trend for AVEO Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVEO Pharmaceuticals Days Inventory Chart

AVEO Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Inventory

Get a 7-Day Free Trial

127.60

AVEO Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Inventory	Get a 7-Day Free Trial															65.51	65.26	62.80	44.87	27.92

Competitive Comparison of AVEO Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, AVEO Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVEO Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AVEO Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where AVEO Pharmaceuticals's Days Inventory falls into.

AVEO Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AVEO Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

	Days Inventory (A: Dec. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (0	+	1.656)	/	1 )	/	4.737	*	365
=	1.656					/	4.737	*	365
=	127.60

AVEO Pharmaceuticals's Days Inventory for the quarter that ended in Sep. 2022 is calculated as:

	Days Inventory (Q: Sep. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2022 )	+	Total Inventories (Q: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2022 )	*	Days in Period
=	( (1.32	+	1.106)	/	2 )	/	3.964	*	365 / 4
=	1.213					/	3.964	*	365 / 4
=	27.92

AVEO Pharmaceuticals (NAS:AVEO) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

AVEO Pharmaceuticals's Inventory Turnover for the three months ended in Sep. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3.964	/	1.213
	=	3.27

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AVEO Pharmaceuticals's Inventory to Revenue for the three months ended in Sep. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.213	/	30.449
	=	0.04

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

AVEO Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of AVEO Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

AVEO Pharmaceuticals (AVEO Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AVEO Pharmaceuticals Inc (NAS:AVEO) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Winter Street, Boston, MA, USA, 02108

Website

https://www.aveooncology.com

AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth factor receptor, or VEGFR, tyrosine kinase inhibitor, or TKI. The group primarily operates in the U.S.

Executives

Jebediah Ledell	officer: Chief Operating Officer	C/O AVEO PHARMACEUTICALS, INC., 30 WINTER STREET, BOSTON MA 02108
Michael P Bailey	director, officer: President & CEO	IMCLONE SYSTEMS INCORPORATED, 180 VARICK STREET, 6TH FLOOR, NEW YORK NY 10014
Michael Ferraresso	officer: Chief Commercial Officer	AVEO PHARMACEUTICALS, INC., 30 WINTER STREET, BOSTON MA 02108
Kevin Joseph Cullen	director	AVEO PHARMACEUTICALS, INC., 30 WINTER STREET, BOSTON MA 02108
Epperly Corinne	director	AVEO PHARMACEUTICALS, INC., 30 WINTER STREET, BOSTON MA 02108
Peter W. Sonsini	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
Florence Anthony A. Jr.	10 percent owner	5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815
Forest Baskett	10 percent owner
Joshua Makower	10 percent owner	1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Scott D Sandell	10 percent owner
Growth Equity Opportunities Iv, Llc	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Mohamad Makhzoumi	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
Erick Lucera	officer: Chief Financial Officer	138 THISTLE ROAD, NORTH ANDOVER MA 08145
Scarlett Spring	director	AVEO PHARMACEUTICALS, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Peter J Barris	10 percent owner	1119 ST PAUL STREET, BALTIMORE MD 21202